real world evidence


Substantiating the real-world value of your pharmaceutical product or medical device is critical for achieving market success. While historically product development has been centered on product quality, clinical efficacy and safety, today you must substantiate and demonstrate your product’s real-world value to a diverse group of stakeholders, including patients, physicians, payers, HTA agencies and regulatory authorities.

Combining consulting and scientific expertise with local knowledge, Kantar helps you identify, quantify and understand the needs of your product’s key stakeholders and the actions required to substantiate and maximize your product’s value. We deliver comprehensive strategies supported by real-world, evidence-based research – ensuring that you are fully prepared for the regulatory approval and risk management processes, access and reimbursement, and provider, payer and patient support and uptake.

Real-World Research and Evidence Capabilities:
  • Observational disease-based studies
  • Burden of disease, cost of illness and treatment pattern
  • Health services research and disease registries
  • Physician-based non-interventional studies (NIS)
  • Patient-based, active surveillance (AS)
  • Public health and population-based epidemiology services
  • Post-authorization safety/effectiveness studies (PASS/PAES)
  • Product utilization, labeling respect, risk minimization plan-related studies
  • Health economics and outcomes research services
  • Risk management and pharmacoepidemiology services


Kantar provides consulting and research to communicate the value and potential for products and services that fall under healthcare regulation and legislation.


Let us know how we can help with your project.
By submitting this form you are opting-in to communications from Kantar and agree to our terms & conditions and privacy policy.